(Q28291290)

https://api.crossref.org/works/10.1016/J.YJMCC.2010.08.012

21 June 2024

0 references

0 references

David Rohde

1

0 references

Henriette Brinks

2

0 references

Julia Ritterhoff

3

0 references

Gang Qui

4

0 references

Shumei Ren

5

0 references

Patrick Most

6

0 references

language of work or name

English

0 references

publication date

May 2011

0 references

20 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

20732326

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732326

full work available at URL

21 June 2024

https://api.elsevier.com/content/article/PII:S0022282810002993?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.08.012

https://api.elsevier.com/content/article/PII:S0022282810002993?httpAccept=text/plain

21 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.08.012

Journal of Molecular and Cellular Cardiology

21 June 2024

published in

0 references

volume

50

0 references

issue

5

0 references

page(s)

777-84

0 references

cites work

Cardiac hypertrophy: the good, the bad, and the ugly

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Gene therapy in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Calcium cycling and signaling in cardiac myocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Is depressed myocyte contractility centrally involved in heart failure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Prospects for gene therapy for heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

S100A1: a calcium-modulating inotropic prototype for future clinical heart failure therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

S100A1: Structure, Function, and Therapeutic Potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Lack of S100A1 in mice confers a gender-dependent hypertensive phenotype and increased mortality after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Cardiac adenoviral S100A1 gene delivery rescues failing myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

The myocardial protein S100A1 plays a role in the maintenance of normal gene expression in the adult heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Ca(2+)-binding proteins in dogs with heart failure: effects of cardiac contractility modulation electrical signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Transcriptional regulation of S100A1 and expression during mouse heart development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Ca2+ -dependent interaction of S100A1 with F1-ATPase leads to an increased ATP content in cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

S100A1: a regulator of myocardial contractility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Distinct subcellular location of the Ca2+-binding protein S100A1 differentially modulates Ca2+-cycling in ventricular rat cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

S100A1 gene transfer: a strategy to strengthen engineered cardiac grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

S100A1 increases the gain of excitation-contraction coupling in isolated rabbit ventricular cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

The C Terminus (Amino Acids 75–94) and the Linker Region (Amino Acids 42–54) of the Ca2+-binding Protein S100A1 Differentially Enhance Sarcoplasmic Ca2+ Release in Murine Skinned Skeletal Muscle Fibers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Interaction of S100A1 with the Ca2+ release channel (ryanodine receptor) of skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

S100A1 and Calmodulin Compete for the Same Binding Site on Ryanodine Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Ca2+ -dependent interaction of S100A1 with the sarcoplasmic reticulum Ca2+ -ATPase2a and phospholamban in the human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

The three-dimensional solution structure of Ca(2+)-bound S100A1 as determined by NMR spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Titin-actin interaction in mouse myocardium: passive tension modulation and its regulation by calcium/S100A1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Titin-isoform dependence of titin-actin interaction and its regulation by S100A1/Ca2+ in skinned myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Cardiac titin: a multifunctional giant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Ca2+ signaling in mouse cardiomyocytes with ablated S100A1 protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Systems approach to understanding electromechanical activity in the human heart: a national heart, lung, and blood institute workshop summary.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Large animal models of heart failure: a critical link in the translation of basic science to clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.08.012

S100A1: a regulator of striated muscle sarcoplasmic reticulum Ca2+ handling, sarcomeric, and mitochondrial function

7 January 2021

10

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.08.012

The small EF-hand Ca2+ binding protein S100A1 increases contractility and Ca2+ cycling in rat cardiac myocytes

21 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.08.012

Ultrastructural distribution of the S100A1 Ca2+-binding protein in the human heart

21 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.08.012

Immunocytochemical localization of S100A1 in mitochondria on cryosections of the rat heart

21 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2010.08.012

21 June 2024

Identifiers